- Home
- CR vs PCVX Comparison
CR vs PCVX Comparison
Compare CR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- PCVX
- Stock Information
- Founded
- CR 1855
- PCVX 2013
- Country
- CR United States
- PCVX United States
- Employees
- CR N/A
- PCVX N/A
- Industry
- CR Metal Fabrications
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- CR Industrials
- PCVX Health Care
- Exchange
- CR Nasdaq
- PCVX Nasdaq
- Market Cap
- CR 8.5B
- PCVX 12.5B
- IPO Year
- CR N/A
- PCVX 2020
- Fundamental
- Price
- CR $152.84
- PCVX $114.24
- Analyst Decision
- CR Strong Buy
- PCVX Strong Buy
- Analyst Count
- CR 6
- PCVX 7
- Target Price
- CR $164.00
- PCVX $147.50
- AVG Volume (30 Days)
- CR 154.3K
- PCVX 1.4M
- Earning Date
- CR 10-21-2024
- PCVX 11-04-2024
- Dividend Yield
- CR 0.54%
- PCVX N/A
- EPS Growth
- CR 25.57
- PCVX N/A
- EPS
- CR 4.15
- PCVX N/A
- Revenue
- CR $2,209,500,000.00
- PCVX N/A
- Revenue This Year
- CR $79.54
- PCVX N/A
- Revenue Next Year
- CR N/A
- PCVX N/A
- P/E Ratio
- CR $36.81
- PCVX N/A
- Revenue Growth
- CR 11.07
- PCVX N/A
- 52 Week Low
- CR $82.57
- PCVX $44.20
- 52 Week High
- CR $162.34
- PCVX $119.50
- Technical
- Relative Strength Index (RSI)
- CR 54.49
- PCVX 76.88
- Support Level
- CR $141.50
- PCVX $112.55
- Resistance Level
- CR $158.62
- PCVX $117.39
- Average True Range (ATR)
- CR 3.92
- PCVX 4.48
- MACD
- CR 0.07
- PCVX 1.90
- Stochastic Oscillator
- CR 66.86
- PCVX 87.56
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into three segments: aerospace and electronics, process flow technologies, and engineered materials. Crane generated approximately $2.1 billion in revenue in 2023.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.